Understanding the pharmacokinetics of Favipiravir: Implications for treatment of influenza and COVID-19

Michael G. Ison*, Marc H. Scheetz

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Article number103204
JournalEBioMedicine
Volume63
DOIs
StatePublished - Jan 2021

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this